<DOC>
	<DOCNO>NCT00902460</DOCNO>
	<brief_summary>CP-690,550 midazolam metabolize similar enzyme liver . This study design ass whether co-administration CP-690,500 midazolam effect metabolism midazolam healthy volunteer .</brief_summary>
	<brief_title>CP-690,550 Midazolam Drug-Drug Interaction Study</brief_title>
	<detailed_description />
	<mesh_term>Tofacitinib</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Healthy male and/or female ( nonchild bear potential ) subject Clinically significant infection within past 3 month History previously untreated infection Mycobacterium tuberculosis Positive screen test hepatitis B surface antigen , antihepatitis C antibody , human immunodeficiency virus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>drug interaction CYP3A4 CYP3A5 midazolam anti-rheumatic agent</keyword>
</DOC>